• Dong-A Pharmaceutical subsidiary Dong-A ST will sell 100,000,000 shares in D&T Holding Company for KRW 39.87 billion, exiting its stake.
• The board decided on the disposal Nov. 5, 2026. Completion is scheduled for Nov. 30, 2026.
• The sale represents 5.94% of Dong-A ST’s equity, aiming to realize investment returns and improve liquidity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dong-A Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261105800409), on November 05, 2026, and is solely responsible for the information contained therein.